Zepbound vs. compounded tirzepatide
US$ 28.23
tirzepatide v mounjaro Wegovy (Semaglutide) vs (Tirzepatide) Retatrutide vs Mounjaro: triple agonist
Description
Much anticipated Phase II results in obesity for Amgens GLP-1 agonist/GIP antagonist showed up to 20% weight loss, but without detailed data the drugs competitiveness is hard to ascertain.
Saxenda Liraglutida
1 High Energy (30 servings)
for body weight, 11 [13.2 to 8.8], 9.4 [11.5 to 7.2], and 11.8 [14.0 to 9.6], respectively
A look at Novo Nordisk, Eli Lilly and other companies' late-stage clinical studies of GLP-1 drugs in indications ranging from neurodegeneration to oncology, and alcoholic liver disease to autoimmune conditions.
